mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |